相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。18F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved-A Critical Review
Domenico Albano et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
Qingqing Pan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
18F-FDG PET or PET/CT in Mantle Cell Lymphoma
Domenico Albano et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Posttreated POEMS Syndrome With Concurrent Follicular Lymphoma Revealed by F-18-FDG and Ga-68-Pentixafor PET/CT
Qingqing Pan et al.
CLINICAL NUCLEAR MEDICINE (2020)
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma
Constantin Lapa et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
68Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT
Yaping Luo et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study
Domenico Albano et al.
CANCERS (2019)
Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [68Ga] Ga-Pentixafor-PET/MRI
Alexander R. Haug et al.
THERANOSTICS (2019)
Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT
Qingqing Pan et al.
CLINICAL NUCLEAR MEDICINE (2018)
Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenstrom Macroglobulinemia
Yaping Luo et al.
CLINICAL NUCLEAR MEDICINE (2018)
Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT
Serkan Kuyumcu et al.
CLINICAL NUCLEAR MEDICINE (2018)
[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia Preliminary Results
Marius E. Mayerhoefer et al.
INVESTIGATIVE RADIOLOGY (2018)
Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics
Stefan Habringer et al.
THERANOSTICS (2018)
CXCR4 Ligands: The Next Big Hit?
Annemiek M. E. Walenkamp et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation
Domenico Albano et al.
LEUKEMIA & LYMPHOMA (2017)
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
Constantin Lapa et al.
THERANOSTICS (2017)
[68Ga] Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F] FDG and laboratory values
Constantin Lapa et al.
THERANOSTICS (2017)
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma
Patricia Balsas et al.
BLOOD (2017)
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
Ken Herrmann et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
Peter Herhaus et al.
HAEMATOLOGICA (2016)
Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin
Susann Stollberg et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
Peter Herhaus et al.
HAEMATOLOGICA (2016)
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
Kathrin Philipp-Abbrederis et al.
EMBO MOLECULAR MEDICINE (2015)
Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides
Joanna Maj et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2015)
Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging
Hans Juergen Wester et al.
THERANOSTICS (2015)
Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1phosphate receptors and integrins
Stephen Middle et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2015)
Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides
R. N. Daggett et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia
Ranjit Banwait et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting
Antonina V. Kurtova et al.
BLOOD (2009)
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia
Hai T. Ngo et al.
BLOOD (2008)
Peripheral T-cell lymphoma following diffuse large B-cell lymphoma associated with celiac disease
Hideki Makishima et al.
INTERNAL MEDICINE (2008)
Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV
MG Narducci et al.
BLOOD (2006)
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
L Trentin et al.
BLOOD (2004)
Chemokine receptor expression in B-cell lymphoproliferative disorders
SWJ Wong et al.
LEUKEMIA & LYMPHOMA (2004)
CXCR4/CD184 immunoreactivity in T-cell non-Hodgkin lymphomas with an overall Th1-Th2+immunophenotype
AP Weng et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Differential expression of chemokine receptors in B cell malignancies
J Dürig et al.
LEUKEMIA (2001)
分享论文
